TY - JOUR
T1 - Clinically relevant small-molecule promotes nerve repair and visual function recovery
AU - Au, Ngan Pan Bennett
AU - Kumar, Gajendra
AU - Asthana, Pallavi
AU - Gao, Fuying
AU - Kawaguchi, Riki
AU - Chang, Raymond Chuen Chung
AU - So, Kwok Fai
AU - Hu, Yang
AU - Geschwind, Daniel H.
AU - Coppola, Giovanni
AU - Ma, Chi Him Eddie
N1 - Funding Information:
This work is supported in part by General Research Fund (GRF) from The Research Grant Council of the Hong Kong Special Administrative Region Government (CityU 11100519 and CityU 11100318), and The Health and Medical Research Fund (HMRF), Food and Health Bureau, Hong Kong Special Administrative Region Government (07181356) award to Chi Ma. The schematic illustrations in Fig. are created with BioRender.com.
Publisher Copyright:
© 2022, The Author(s).
PY - 2022/10/1
Y1 - 2022/10/1
N2 - Adult mammalian injured axons regenerate over short-distance in the peripheral nervous system (PNS) while the axons in the central nervous system (CNS) are unable to regrow after injury. Here, we demonstrated that Lycium barbarum polysaccharides (LBP), purified from Wolfberry, accelerated long-distance axon regeneration after severe peripheral nerve injury (PNI) and optic nerve crush (ONC). LBP not only promoted intrinsic growth capacity of injured neurons and function recovery after severe PNI, but also induced robust retinal ganglion cell (RGC) survival and axon regeneration after ONC. By using LBP gene expression profile signatures to query a Connectivity map database, we identified a Food and Drug Administration (FDA)-approved small-molecule glycopyrrolate, which promoted PNS axon regeneration, RGC survival and sustained CNS axon regeneration, increased neural firing in the superior colliculus, and enhanced visual target re-innervations by regenerating RGC axons leading to a partial restoration of visual function after ONC. Our study provides insights into repurposing of FDA-approved small molecule for nerve repair and function recovery.
AB - Adult mammalian injured axons regenerate over short-distance in the peripheral nervous system (PNS) while the axons in the central nervous system (CNS) are unable to regrow after injury. Here, we demonstrated that Lycium barbarum polysaccharides (LBP), purified from Wolfberry, accelerated long-distance axon regeneration after severe peripheral nerve injury (PNI) and optic nerve crush (ONC). LBP not only promoted intrinsic growth capacity of injured neurons and function recovery after severe PNI, but also induced robust retinal ganglion cell (RGC) survival and axon regeneration after ONC. By using LBP gene expression profile signatures to query a Connectivity map database, we identified a Food and Drug Administration (FDA)-approved small-molecule glycopyrrolate, which promoted PNS axon regeneration, RGC survival and sustained CNS axon regeneration, increased neural firing in the superior colliculus, and enhanced visual target re-innervations by regenerating RGC axons leading to a partial restoration of visual function after ONC. Our study provides insights into repurposing of FDA-approved small molecule for nerve repair and function recovery.
UR - http://www.scopus.com/inward/record.url?scp=85139237929&partnerID=8YFLogxK
U2 - 10.1038/s41536-022-00233-8
DO - 10.1038/s41536-022-00233-8
M3 - Article
AN - SCOPUS:85139237929
SN - 2057-3995
VL - 7
JO - npj Regenerative Medicine
JF - npj Regenerative Medicine
IS - 1
M1 - 50
ER -